Literature DB >> 19609420

Multimodal therapy for patients with acute ischemic stroke : outcomes and related prognostic factors.

Seung Young Jeong1, Seung Soo Park, Eun-Jeong Koh, Jong Pil Eun, Ha Young Choi.   

Abstract

OBJECTIVE: The objectives of this study were to analyze the recanalization rates and outcomes of multimodal therapy that consisted of sequential intravenous (IV)/intra-arterial (IA) thrombolysis, mechanical thrombolysis including mechanical clot disruption using microcatheters and microwires, balloon angioplasty, and stenting for acute ischemic stroke, and to evaluate the prognostic factors related to the outcome.
METHODS: Fifty patients who were admitted to the hospital within 8 hours from ischemic symptom onset were retrospectively analyzed. Initial IV thrombolysis and subsequent cerebral angiography were performed in all patients. If successful recanalization was not achieved by IV thrombolysis, additional IA thrombolysis with mechanical thrombolysis, including balloon angioplasty and stenting, were performed. The outcomes were assessed by the National Institute of Health Stroke Scale (NIHSS) change and modified Rankin scale (mRS) and prognostic factors were analyzed.
RESULTS: Successful recanalization was achieved in 42 (84%) of 50 patients, which consisted of 8 patients after IV thrombolysis, 19 patients after IA thrombolysis with mechanical clot disruption, and 15 patients after balloon angioplasty or stenting. Symptomatic hemorrhage occurred in 4 (8%) patients. Good outcomes were achieved in 76% and 70% of patients upon discharge, and 93% and 84% of patients after 3 months according to the NIHSS change and mRS. The initial clinical status, recanalization achievement, and presence of symptomatic hemorrhage were statistically related to the outcomes.
CONCLUSION: Multimodal therapy may be an effective and safe treatment modality for acute ischemic stroke. Balloon angioplasty and stenting is effective for acute thrombolysis, and produce higher recanalization rates with better outcomes.

Entities:  

Keywords:  Acute ischemic stroke; Balloon angioplasty; Mechanical thrombolysis; Prognostic factors; Stenting

Year:  2009        PMID: 19609420      PMCID: PMC2711234          DOI: 10.3340/jkns.2009.45.6.360

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  24 in total

1.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.

Authors:  Thomas Wolfe; Jose I Suarez; Robert W Tarr; Elisabeth Welter; Dennis Landis; Jeffrey L Sunshine; Osama O Zaidat
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 May-Jun       Impact factor: 2.136

3.  Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis.

Authors:  Alex Abou-Chebl; Christopher T Bajzer; Derk W Krieger; Anthony J Furlan; Jay S Yadav
Journal:  Stroke       Date:  2005-09-22       Impact factor: 7.914

4.  Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke.

Authors:  Kyung Yul Lee; Dong Ik Kim; Seo Hyun Kim; Seung Ik Lee; Hae Woong Chung; Yong Woon Shim; Seung Min Kim; Ji Hoe Heo
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

5.  Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke.

Authors:  A J Ringer; A I Qureshi; R D Fessler; L R Guterman; L N Hopkins
Journal:  Neurosurgery       Date:  2001-06       Impact factor: 4.654

6.  Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke?

Authors:  Elizabeth A Noser; Hashem M Shaltoni; Christiana E Hall; Andrei V Alexandrov; Zsolt Garami; Edwin D Cacayorin; Joon K Song; James C Grotta; Morgan S Campbell
Journal:  Stroke       Date:  2004-12-29       Impact factor: 7.914

7.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

8.  Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.

Authors:  Osama O Zaidat; Jose I Suarez; Concepcion Santillan; Jeffrey L Sunshine; Robert W Tarr; Vanessa H Paras; Warren R Selman; Dennis M D Landis
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

9.  Urgent stenting for patients with acute stroke due to atherosclerotic occlusive lesions of the cervical internal carotid artery.

Authors:  Naoko Miyamoto; Isao Naito; Shin Takatama; Tatsuya Shimizu; Tomoyuki Iwai; Hidetoshi Shimaguchi
Journal:  Neurol Med Chir (Tokyo)       Date:  2008-02       Impact factor: 1.742

10.  Simple microwire and microcatheter mechanical thrombolysis with adjuvant intraarterial urokinase for treatment of hyperacute ischemic stroke patients.

Authors:  Dong Joon Kim; Dong Ik Kim; Joon Soo Byun; Jin Young Jung; Sang Hyun Suh; Eung Yeop Kim; Kyung-Yul Lee; Ji Hoe Heo
Journal:  Acta Radiol       Date:  2008-04       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.